Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

Share Price is delayed by 15 minutes
Get Live Data
445.00    8.50 (1.95%)
Bid:
444.50
Ask:
445.00
Spread: 0.50 (0.112%)
Market Cap: £658.17m
CRE Live PriceLast checked at - London Stock Exchange

Intraday Conduit Hldg Share Chart

Interim Management Statement

26 Jul 2010 07:00

RNS Number : 8697P
Creston PLC
26 July 2010
 



 

 

 

Press Release 26 July 2010

 

Creston plc

Interim Management Statement 

 

Creston plc ("Creston" or the "Group") (LSE: CRE), the Insight and Communications Group, announces its interim management statement for the period 1 April 2010 to 25 July 2010.

 

Trading

 

As announced in Creston's preliminary statement on 28 June 2010 the Group has started the new financial year positively. The continuing Group post the disposal of DLKW Group on 14 July 2010 has delivered like-for-like revenue growth of 11 per cent for the 3 month period to 30 June 2010. This compares favourably to the 6 per cent like-for-like revenue decline reported for the comparable quarter of 2009 and the 4 per cent revenue decline reported for the financial year ending 31 March 2010.

 

The positive start to the new financial year has been driven by a number of new business wins including Astellas, Guinness, GSK, Shire Pharmaceuticals, Smith & Nephew, Sony Professional Services and ViiV.

 

Balance Sheet

 

Following the disposal of DLKW the Group had a positive cash balance of over £1 million on 14 July 2010 and access to an unutilised bank facility of £25 million.

 

Outlook

As a result of the first quarter growth in like-for-like revenue, demonstrating the quality and resilience of the continuing Group, and the momentum in new business wins, trading continues in line with management's and market expectations.

 

For further information, please contact:

 

Creston plc

020 7930 9757

Don Elgie, Chief Executive

 

Barrie Brien, COO/CFO

 

www.creston.com

 

 

 

M:Communications

 

Elly Williamson

020 7920 2339

 

 

 

 

About Creston plc

 

§ Creston is an Insight and Communications company for the 21st century. It offers clients more seamless access to the most innovative marketing insights and communications services to help grow their brands in a rapidly-changing consumer world. Our companies draw upon the collective knowledge, expertise and services from across-the-Group, so that their clients receive the best advice and achieve the best results no matter what the medium. By working together, whether on research or as full-scale marketing partners, our companies continuously innovate to make more things possible for their clients and people.

 

§ Creston companies offer a range of marketing services, such as advertising, direct and digital marketing, market research, public relations and healthcare marketing to a broad range of blue-chip clients including: Amazon, AstraZeneca, Aviva, Bayer, BMW, BT, Burger King, Canon, COI Communications, Danone, Diageo, First Direct, GlaxoSmithKline, HTCJaguar, Kimberly-Clark, Land Rover, Lexus, Lloyds Black Horse, Nissan, O2, Pfizer, RocheDiagnostics, Royal Mail, Sainsbury's, Tesco, Thorpe Park, Toshiba, Toyota, T-Mobile, Tropicana, Unilever, Vodafone and Walkers.

 

§ Creston's share price is quoted in the Financial Times, The Daily Telegraph, The Times and the London Evening Standard.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEASXDALLEEFF
Date   Source Headline
22nd Jul 20244:51 pmRNSNotice of Results
12th Jul 20246:21 pmRNSHolding(s) in Company
24th Jun 20247:00 amRNSDirector/PDMR Shareholding
24th Jun 20247:00 amRNSDirector/PDMR Shareholding
12th Jun 202412:48 pmRNSHolding(s) in Company
30th May 20247:00 amRNSHolding(s) in Company
28th May 20247:00 amRNSDirector/PDMR Shareholding
23rd May 20243:26 pmRNSDirector/PDMR Shareholding
23rd May 20247:00 amRNSHolding(s) in Company
23rd May 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
22nd May 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
21st May 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
17th May 20244:21 pmRNSDirector/PDMR Shareholding
16th May 20247:00 amRNSResult of AGM
15th May 20247:00 amRNSQ1 Trading Update
15th May 20247:00 amRNSDirectorate Change
3rd May 20244:00 pmRNSNotice of Results
30th Apr 20247:00 amRNSHolding(s) in Company
25th Apr 20244:11 pmRNSHolding(s) in Company
19th Apr 20247:00 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSHolding(s) in Company
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
12th Apr 20247:00 amRNSNotice of AGM
8th Apr 20244:34 pmRNSDirector/PDMR Shareholding
4th Apr 20243:52 pmRNSDirector/PDMR Shareholding
28th Mar 20243:53 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSDirector/PDMR Shareholding
25th Mar 20244:49 pmRNSDirector/PDMR Shareholding
25th Mar 20244:49 pmRNSDirector/PDMR Shareholding
25th Mar 20244:48 pmRNSDirector/PDMR Shareholding
25th Mar 20244:48 pmRNSDirector/PDMR Shareholding
12th Mar 20243:11 pmRNSHolding(s) in Company
7th Mar 20245:52 pmRNSPurchase of Shares by Employee Benefit Trust
6th Mar 20243:53 pmRNSPurchase of Shares by Employee Benefit Trust
6th Mar 20247:00 amRNSHolding(s) in Company
5th Mar 20244:48 pmRNSPurchase of Shares by Employee Benefit Trust
4th Mar 20243:58 pmRNSPurchase of Shares by Employee Benefit Trust
1st Mar 20244:00 pmRNSPurchase of Shares by Employee Benefit Trust
28th Feb 20241:40 pmRNSAnnual Financial Report
28th Feb 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
28th Feb 20247:00 amRNSHolding(s) in Company
26th Feb 20245:44 pmRNSPurchase of Shares by Employee Benefit Trust
26th Feb 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
21st Feb 20247:00 amRNSAppointment of Senior Independent Director
21st Feb 20247:00 amRNSPreliminary results for the year ended 31/12/2023
13th Feb 20247:00 amRNSNotice of Full Year 2023 Trading Update
29th Jan 20247:00 amRNSPerformance Update
25th Jan 20247:00 amRNSJanuary 2024 Trading Update
15th Jan 20247:00 amRNSNotice of 1 January 2024 Renewals Trading Update
14th Dec 20235:39 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.